Letter to the Editor
Response: Clinical Importance of Pentraxin 3 in Autoimmune Diseases

https://doi.org/10.1016/j.arcmed.2016.08.006Get rights and content

Section snippets

Acknowledgments

This work was partly supported by grants from the Key Project of the Education Department of Anhui Province Natural Science Research (Code: KJ2012A165, KJ2014A127) and Anhui Provincial Natural Science Foundation (Code: 1308085MH169).

Conflict of interest: The authors declare no conflicts of interest.

References (8)

  • M. Noordzij et al.

    Systematic reviews and meta-analyses: when they are useful and when to be careful

    Kidney Int

    (2009)
  • X.L. Huang et al.

    Association of pentraxin 3 with autoimmune diseases: a systematic review and meta-analysis

    Arch Med Res

    (2016)
  • R. Assandri et al.

    Pentraxin 3 plasma levels and disease activity in systemic lupus erythematosus

    Autoimmune Dis

    (2015)
  • P. Cieślik et al.

    Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus

    Autoimmunity

    (2015)
There are more references available in the full text version of this article.

Cited by (0)

View full text
Copyright © 2016 IMSS. Published by Elsevier Inc.